Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 1 - Drugs for disorders of the alimentary tract or the digestive system
Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
05/2003
05/28/2003EP1313491A1 Bioactive fraction of eurycoma longifolia
05/28/2003EP1313490A1 Pharmaceutical composition comprising wikstromol and/or matairesinol, its use as hepatoprotectant and process for their isolation from cedrus deodara
05/28/2003EP1313489A2 Pharmaceutical compositions for the treatment of mucositis, stomatitis and behcet's syndrome
05/28/2003EP1313481A1 Pharmaceutical composition comprising condensed indole compound
05/28/2003EP1313470A1 Novel alicyclic imidazoles as h 3 agents
05/28/2003EP1313469A1 Methods of drug delivery to hepatocytes and treatment of flaviviridae infections
05/28/2003EP1313461A2 The use of benzylideneaminoguanidines and hydroxyguanidines as melanocortin receptor ligands
05/28/2003EP1313460A2 Therapeutic use and formulation of (-)-tramadol
05/28/2003EP1313440A1 Dental products comprising bone growth enhancing peptide
05/28/2003EP1313379A2 Alpha-(1,4)linked glucose polymers containing oral compositions to alleviate or prevent tooth damage
05/28/2003EP1313377A2 Treatment of helicobacter with isothiocyanates
05/28/2003EP1244439A4 Oral glutamine in the prevention of neonatal necrotizing enterocolitis and other gastrointestinal mucosal damage
05/28/2003EP1175149B9 Disinfecting composition based on h2o2, acids and metal ions
05/28/2003EP1161251B1 Use of a composition comprising klebsiella pneumoniae proteoglycans, and bacterial ribosomes or ribosomal rna's for the preparation of a medicament for treating and/or preventing periodontal diseases
05/28/2003EP1150664B1 Novel use of orexin receptor antagonists
05/28/2003EP1146885B1 Pre-conditioning against cell death
05/28/2003EP1054678B1 Combination of steroid and polyunsaturated fatty acids for treatment of inflammatory conditions
05/28/2003EP1039904B1 Synergistic antimicrobial compositions
05/28/2003EP1015444B1 Pyrimidine derivatives and processes for the preparation thereof
05/28/2003EP0968700B1 Material intended to remineralise organomineral tissues
05/28/2003EP0814792B1 Mercapto and seleno derivatives as inhibitors of nitric oxide synthase
05/28/2003EP0788509B1 Therapeutic peptide derivatives
05/28/2003CN1420933A Method of inducing angiogenesis by micro-organs
05/28/2003CN1420891A Pharmaceutical compound
05/28/2003CN1420890A Tricyclic imidazopyridines
05/28/2003CN1420889A Pharmaceutically active isoindoline derivs.
05/28/2003CN1420888A Substd. pyrazoloÒÇö4,3-eÒÇòdiazepines, pharmaceu-tical compositions contg. them, use as medicinal products and processes for preparing them
05/28/2003CN1420887A 8-quinolinxanthine and 8-isoquinolinxanthine derivs. as PDE 5 inhibitors
05/28/2003CN1420885A Therapeutically useful new salts of CCK inhibitors, process for preparation thereof and pharmaceutical preparations contg. them
05/28/2003CN1420881A Beta-amino acid derivs. as inhibitors of matrix metalloproteases and TNF-alpha
05/28/2003CN1420878A Compound with growth hormone releasing properties
05/28/2003CN1420872A Caspase inhibitors and use thereof
05/28/2003CN1420785A Method of treating cancer with anti-neurotrophin agents
05/28/2003CN1420781A Bifidobacteria capable of preventing diarrhea
05/28/2003CN1420780A Pharmaceutical compositions including alginates
05/28/2003CN1420779A Nucleoside analogs with carboxamidine-modified bicyclic base
05/28/2003CN1420778A Remedies for periodontosis
05/28/2003CN1420772A Prophylactic and therapeutic use of oltipraz as antifibrotic and anticirrhotic agent in liver and pharmaceutical composition contg. oltipraz
05/28/2003CN1420770A Method of delivery of cetyl myristoleate
05/28/2003CN1420767A Pharmaceutical formulation contg. tolterodine and its use
05/28/2003CN1420761A Composition for inhalation comprising delta-9-tetrahydrocannabinol in semiaqueous solvent
05/28/2003CN1420723A Compositions and methods for L-nucleosides, and their analogs
05/28/2003CN1420120A Medicinal preparation contg. 1-N-ethyl vistamycin or its salt, and process for preparing same
05/28/2003CN1419938A Fusion anticaries DNA vaccine and prepring method thereof
05/28/2003CN1419937A Immune anticaries DNA vaccine, preparing method and use thereof
05/28/2003CN1419935A Specific medicine for treatiug AIDs, cancer and hepatitis, and health product for recovery
05/28/2003CN1419926A Medicine for treating bile backflow gastritis
05/28/2003CN1419925A Tonic Wines and their preparation method
05/28/2003CN1419914A Mild purgative
05/28/2003CN1109745C Ginseng-tortoise liquor and its preparing process
05/28/2003CN1109684C Novel compound form
05/28/2003CN1109675C Arylpyrimidine derivs.
05/28/2003CN1109674C Imidazole deriv. and process for preparing same
05/28/2003CN1109552C Enteritis curing capsule
05/27/2003US6569904 Via administration of toremifene for treatment or prevention of systemic/pulmonary hypertension, fibrosis, bronchial asthma, respiratory distress syndrome, myocardial infarction, thrombosis, congestive heart failure, and renal failure
05/27/2003US6569890 Cyclic AMP-specific phosphodiesterase inhibitors
05/27/2003US6569888 Such as ethyl-N-(dichlorobenzyl)-4-(3-hydroxypropylthio) indole-2-carboxylate; for treatment of arthritis
05/27/2003US6569871 Substituted imidazole compounds
05/27/2003US6569855 Particularly zinc metalloprotease activity for treatment of variety of maladies involving inflammation and/or tissue integrity
05/27/2003US6569842 Method of preparing and use of prodrugs of betulinic acid derivatives
05/27/2003US6569649 Compositions and methods for saccharide synthesis
05/27/2003US6569468 Treatment of urogenital disorders, menstrual cramps
05/27/2003US6569463 Encapsulation coat includes different combinations of pharmaceutical active ingredients, hydrophilic and lipophilic surfactants, and triglycerides
05/27/2003US6569460 Film-coated tablet for improved upper gastrointestinal tract safety
05/27/2003US6569453 No enteric layers and are suitable for oral administration
05/27/2003US6569424 A probiotic formulation of Escherichia coli strain BU-230-98 ATCC Deposit No. 20226 (DSM 12799); containing at least one volatile fraction (VF) of a plant extract
05/27/2003CA2277020C Material intended to remineralise organomineral tissues
05/27/2003CA2268847C Substituted oximes derivatives useful as neurokinin antagonists
05/27/2003CA2231558C .gamma.-rar antagonist ligand or .alpha.-rar agonist ligand as an apoptosis inhibitor
05/27/2003CA2176229C Improved interferon polymer conjugates
05/27/2003CA2084961C Tissue protective tocopherol analogs
05/27/2003CA2066104C Benzazepine derivatives as vasopressin antagonists
05/22/2003WO2003042405A2 Methods of isolation, expansion and differentiation of fetal stem cells from chorionic villus, amniotic fluid, and placenta and therapeutic uses thereof
05/22/2003WO2003042397A2 A method of detecting and/or identifying adeno-associated virus (aav) sequences and isolating novel sequences identified thereby
05/22/2003WO2003042390A1 Mammalian protein phosphatases
05/22/2003WO2003042377A1 Expansion of t cells in vitro and expanded t cell populations
05/22/2003WO2003042375A1 Stem cells originating in salivary duet epithelial cells and use thereof
05/22/2003WO2003042359A2 Histamine receptor h3 polynucleotides
05/22/2003WO2003042247A2 Modified anti-tnf alpha antibody
05/22/2003WO2003042237A1 Peptide derivative, pharmaceutically acceptable salt thereof, process for producing the same, and use thereof
05/22/2003WO2003042216A1 Polycyclic guanine derivative phosphodiesterase v inhibitors
05/22/2003WO2003042214A2 A2b adenosine receptor antagonists
05/22/2003WO2003042211A1 Phenyl substituted triazoles and their use as selective inhibors of akl5 kinase
05/22/2003WO2003042207A1 Thiazolyl substituted triazoles as alk5 inhibitors
05/22/2003WO2003042205A1 Piperidine derivatives and their use as modulators of chemokine receptor activity (especially ccr5)
05/22/2003WO2003042197A1 Oligopeptides and compositions containing them as cathepsin s inhibitors
05/22/2003WO2003042191A1 Benzamide and heteroarylamide as p2x7 receptor antagonists
05/22/2003WO2003042190A1 N-alkyl-adamantyl derivatives as p2x7-receptor antagonists
05/22/2003WO2003042178A1 Novel piperidine derivatives as modulators of chemokine receptors
05/22/2003WO2003042177A1 Piperidine derivatives and their use as modulators of chemokine receptor activity (especially ccr5)
05/22/2003WO2003042176A1 Azabicyclo compound, matrix metalloprotease inhibitor, and skin preparation
05/22/2003WO2003042174A1 Cannabinoid receptor ligands
05/22/2003WO2003042173A1 Nk1 antagonists
05/22/2003WO2003042113A1 Production of cell suspensions
05/22/2003WO2003041717A1 Persistent filmy preparation for topical administration containing prostaglandin derivative
05/22/2003WO2003041716A1 Dosage unit comprising a prostaglandin analog for treating constipation
05/22/2003WO2003041715A1 Substituted 1,4-benzodiazepines and uses thereof for the treatment of cancer
05/22/2003WO2003041714A1 Benzotriazepines as gastrin and cholecystokinin receptor ligands
05/22/2003WO2003041713A1 Use of therapeutic dosages for nitric oxide donors which do not significantly lower blood pressure or pulmonary artery pressure
05/22/2003WO2003041711A1 Piperazine bis-amide derivatives and their use as antagonists of the orexin receptor
1 ... 878 879 880 881 882 883 884 885 886 887 888 889 890 891 892 893 894 895 896 897 898 ... 1258